Glaukos Corporation
GKOS
Rang în acțiuni
#2086
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Preț acțiune
$166.79
Ultima sincronizare: 2026-10-19
Capitalizare de piață
$9.84B
Schimbare (1 zi)
1.44%
Schimbare (1 an)
109.88%
Țară
US
Tranzacționează Glaukos Corporation (GKOS)
Categorie
Healthcare
Raport P/S pentru Glaukos Corporation (GKOS)
Raport P/S la data de October 2026 TTM: 16.16
Conform celor mai recente rapoarte financiare și prețului acțiunilor Glaukos Corporation, raportul P/S actual (TTM) este 16.16. La sfârșitul anului 2023, compania avea un P/S de 12.23.
Istoricul raportului P/S pentru Glaukos Corporation din 2012 până în 2026
Raport P/S la sfârșitul fiecărui an
| An | Raport P/S | Schimbă |
|---|---|---|
| 2026 (TTM) | 16.16 | -21.67% |
| 2024 | 20.63 | 68.61% |
| 2023 | 12.23 | 66.98% |
| 2022 | 7.33 | 4.41% |
| 2021 | 7.02 | -52.86% |
| 2020 | 14.89 | 73.38% |
| 2019 | 8.59 | -20.84% |
| 2018 | 10.85 | 95.86% |
| 2017 | 5.54 | -43.91% |
| 2016 | 9.87 | 64.08% |
| 2015 | 6.02 | -64.69% |
| 2014 | 17.04 | -54.05% |
| 2013 | 37.09 | 45.31% |
| 2012 | 25.53 | 0.00% |
Raport P/S pentru companii similare sau competitoare
| Companie | Raport P/S | Diferență raport P/S | Țara |
|---|---|---|---|
| 3.82 | -76.33% |
US
|
|
| 2.78 | -82.77% |
IE
|
|
| 4.18 | -74.14% |
US
|
|
| 2.97 | -81.62% |
US
|
|
| - | - |
DE
|
